Article Details

Lynparza approved in Japan for early breast cancer - AstraZeneca - Cision News

Retrieved on: 2022-08-25 06:08:23

Tags for this article:

Click the tags to see associated articles and topics

Lynparza approved in Japan for early breast cancer - AstraZeneca - Cision News. View article details on hiswai:

Excerpt

AstraZeneca and MSD's Lynparza (olaparib) has been approved in Japan for the adjuvant treatment of patients with BRCA-mutated (BRCAm), ...

Article found on: news.cision.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up